ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas A. Vassiliades, Jr
James L. Nielsen
James L. Lonquist
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vassiliades, T. A.
Right arrow Articles by Lonquist, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vassiliades, T. A., Jr
Right arrow Articles by Lonquist, J. L.
Related Collections
Right arrow Minimally invasive surgery

Ann Thorac Surg 2002;74:S1383-S1389
© 2002 The Society of Thoracic Surgeons


Supplement: Cardiothoracic Techniques and Technologies

Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial

Thomas A. Vassiliades, Jr, MDa*, James L. Nielsen, MDa, James L. Lonquist, MDa

a Pensacola Heart Institute, Sacred Heart and Baptist Hospitals, Pensacola, Florida, USA

* Address reprint requests to Dr Vassiliades, Cardiothoracic Surgical Associates of Northwest Florida, 5151 North Ninth Avenue, Suite 200, Pensacola, FL 32504 USA
e-mail: vassiliades{at}pol.net

Presented at the Eighth Annual Cardiothoracic Techniques and Technologies Meeting 2002, Miami Beach, FL, Jan 23–26, 2002.


    Abstract
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
BACKGROUND: Several techniques are being used to perform off-pump coronary artery bypass (OPCAB) grafting. This three-armed clinical trial was performed to determine whether one OPCAB method of coronary perfusion was superior over the others with respect to myocardial protection and performance.

METHODS: Over the course of 11 months, 151 consecutive unselected patients underwent elective first-time OPCAB grafting by sternotomy performed by a single surgeon. Patients were prospectively randomized to receive one of three OPCAB coronary perfusion treatments: (1) no coronary perfusion (NCP), ie, OPCAB using no coronary perfusion during the distal anastomosis or graft perfusion after the distal anastomosis until all the proximal anastomoses were completed; (2) passive coronary perfusion (PCP), providing distal coronary perfusion during the anastomosis and immediate graft perfusion after the distal anastomosis by means of a passive cannula from the aorta; or (3) active coronary perfusion (ACP), providing assisted distal coronary perfusion and graft perfusion by means of an in-line pump (perfusion-assisted direct coronary artery bypass. Hemodynamic and biochemical data were recorded to disc continuously throughout the operation and postoperatively.

RESULTS: With no statistically significant differences in the three treatment groups with respect to patient age, left ventricular systolic or diastolic function, and extent and distribution of coronary disease or grafts performed, cardiac performance postoperatively was superior in the active coronary perfusion group compared to the groups receiving either passive coronary perfusion or no coronary perfusion (p < 0.001). In addition, troponin I levels were lower in the coronary perfusion groups (PCP and ACP) (p = 0.023).

CONCLUSIONS: Providing active coronary perfusion during the anastomosis and after each distal anastomosis by using an in-line pump resulted in superior myocardial protection and performance during OPCAB surgery when compared to either no coronary perfusion or passive coronary perfusion.


    Introduction
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
With refinement of devices and methods, off-pump coronary artery bypass grafting continues to become less technically demanding. Complete revascularization performed off pump is now fairly routine in many centers throughout the world [13]. However, myocardial dysfunction and injury due to transient coronary occlusion continues to be a significant concern [4, 5]. In the past, these concerns have been addressed by the use of ischemic preconditioning of the target coronary bed with variable success [5]. A more recent approach has been to use distal coronary bed perfusion during the distal anastomosis followed by continued perfusion through the completed graft. Distal coronary bed perfusion can be provided either passively, by means of an intracoronary shunt or a shunt from the aorta, or actively, by using a shunt with an in-line pump from the ascending aorta (perfusion assisted direct coronary artery bypass [PADCAB]) [69]. Despite reports of success with each of these methods, no study has been performed to assess the effectiveness of these different techniques in a prospective randomized fashion. This three-armed, prospective, randomized trial compared the myocardial protection and performance characteristics of the techniques of off-pump grafting with the following three techniques: (1) no coronary perfusion (NCP); (2) passive coronary perfusion (PCP); and (3) active coronary perfusion (ACP).


    Patients and methods
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
A total of 151 consecutive, unselected patients were allocated randomly to receive one of the three treatments described above. All operations were performed by the same surgeon (T.A.V.) at Sacred Heart and Baptist Hospitals of Pensacola, FL. Randomization was performed by the method described by Altman and Bland [10]. The institutional review boards of both hospitals approved the study and the patients gave their informed consent. Inclusion criteria included all patients for elective first-time coronary artery bypass grafting except emergency cases, reoperative bypass grafting, or bypass grafting using a nonsternotomy approach. No patients were excluded on the basis of coronary anatomy, left ventricular function, or comorbid risk factors. During the study period (11 months), every elective first-time CABG patient (excluding those undergoing operation with nonsternotomy approaches) was entered into the study, and an OPCAB procedure was performed by this surgeon (T.A.V.). Nonoperative patient care providers were blinded, and management was based on unbiased, criteria-driven protocols.

Patient characteristics
There was no difference in base line characteristics of the three patient groups (Table 1). Patient data were collected and analyzed according to the guidelines and definitions of The Society of Thoracic Surgeons (STS) National Cardiac Surgery Database. All patients were receiving aspirin (81 to 325 mg) preoperatively.


View this table:
[in this window]
[in a new window]
 
Table 1. Patient Characteristics

 
Surgical aspects
Anesthetic technique was standardized for all patients. The heart was exposed through a full median sternotomy, and the OPCAB Elite system (Genzyme Biosurgery, Cambridge, MA) was used in all operations. A heparin dose of 4 mg/kg was administered and the activated clotting time was kept at 400 seconds or more in all cases. Silicone elastomer vessel loops (Quest Medical Inc, Allen, TX) and a plastic platform (Genzyme Biosurgery, Cambridge, MA) were used to stabilize and occlude the coronary arteries during grafting.

The grafting sequence was similar in all patients. The left anterior descending coronary artery was grafted first; follwed by the anterior, lateral, and posterior vessels. Exceptions to this rule were totally occluded vessels that received collaterals from another coronary artery that also required a bypass graft. In this case, the collaterized vessel was grafted first. Distal anastomoses were performed before the proximal anastomoses. Proximal anastomoses were performed under a partial occlusion clamp. In the presence of an atherosclerotic ascending aorta, the proximal anastomoses were placed to the in situ IMA pedicle and aortic clamping was avoided. Patients were fully reversed with protamine sulfate. The activated clotting time was restored to baseline.

The three treatment arms of the study are outlined below.

NCP group
In the no coronary perfusion (NCP) group, no distal coronary bed perfusion was provided during the distal anastomosis except in cases in which significant ischemic or hemodynamic changes occurred. A shunt was used when grafting the main right coronary artery unless it was totally occluded. Upon completion of the distal anastomosis, distal coronary bed perfusion was reestablished through the stenotic native coronary artery only. The grafts were not perfused until all proximal anastomoses were completed at the conclusion of the operation. Low-dose nitroglycerin (5 to 20 µg/L) was given intravenously throughout the operation as long as the mean arterial pressure remained within the normal range.

PCP group
In the passive coronary perfusion (PCP) group, a DLP aortic root cardioplegia cannula (11F, 9 gauge; Medtronic DLP, Grand Rapids, MI) was placed in a nondiseased portion of the ascending aorta and secured with a pursestring suture. The coronary perfusate was administered passively from the ascending aorta through a multiple perfusion set (Medtronic DLP). A soft 2- or 3-mm olive-tipped catheter (Medtronic DLP) was passed distally through the coronary arterotomy to provide distal coronary perfusion during the anastomosis. After completion of each free graft, the proximal end was connected to an arm of the delivery set so as to provide immediate and continuous coronary blood flow to the myocardial bed. The flow to each coronary bed was directly dependent on the mean arterial pressure in the ascending aorta and the number of grafts connected to the set. Flows ranged from 10 to 50 mL/min per graft. Perfusion to each graft was terminated while the proximal anastomosis was completed. Low-dose nitroglycerin (5 to 20 µg/L) was given intravenously throughout the operation as long as the mean arterial pressure remained within the normal range.

ACP group
In the active coronary perfusion (ACP) group, patients underwent perfusion assisted direct coronary artery bypass (PADCAB) [6]. As in the PCP patients, a DLP aortic root cardioplegia cannula (11F, 9-gauge; Medtronic DLP) was placed in a nondiseased portion of the ascending aorta and secured with a pursestring suture. The cannula was then connected to the Myocardial Protection System (MPS) perfusion delivery system (Quest Medical Inc, Allen, TX). A soft 2- or 3-mm olive-tipped catheter (Medtronic DLP) was passed distally through the coronary arterotomy to provide distal coronary perfusion during the anastomosis. After completion of each free graft, the proximal end of the graft was connected to an arm of the delivery set so as to provide immediate and continuous coronary blood flow to the myocardial bed (Fig 1). Arterial blood was removed from the aorta and actively pumped into the distal coronary bed during and after the anastomosis. The Myocardial Protection System allowed monitoring of delivery line pressure (mm Hg), graft infusion pressure (mm Hg), and flow (cc/min). Unlike the PCP approach, the ACP set-up allows administration of coronary perfusate at suprasystemic pressures, as it is not as dependent on the pressure in the ascending aorta or on the number of grafts being supplied with perfusate at one time. Additionally, low-dose nitroglycerin (5 to 20 µg/L) was used as an additive to the reperfusate in all completed grafts. Flows ranged from 20 to 150 mL/min per graft. Perfusion to each graft was terminated while the proximal anastomosis was completed.



View larger version (54K):
[in this window]
[in a new window]
 
Fig 1. Active coronary perfusion using the perfusion-assisted direct coronary artery bypass system. Aortic blood is directed from the aortic cannula (A) through the in-line pump (Quest MPS system) to the multiple perfusion manifold (B), and finally to the grafts (C) or as a shunt during distal anastomosis (D). A feedback line (E) is used to monitor perfusion pressure.

 
Data collection
Preoperative variables were collected according to the STS National Cardiac Surgery Database. Intraoperative and postoperative variables consisted of continuous ST segment analysis in three leads, nasopharyngeal temperature, central venous pressure, pulmonary artery pressure (mean, systolic, and diastolic), systemic arterial pressure (mean, systolic, and diastolic), pulmonary capillary wedge pressure, continuous cardiac output and index, mixed venous saturation, systemic arterial oxygen saturation, inspired oxygen saturation, serum electrolytes, hemoglobin, platelet count, coronary occlusion times, total operating times, fluid administration, shed mediastinal blood, autotransfused blood volume, serum lactate levels, Troponin I levels, creatinine phosphokinase-MB levels, mechanical ventilation time, lengths of stay in the intensive care unit (ICU) and the hospital, net fluid gain, and use of inotropic support or intraaortic balloon pump.

Myocardial performance was assessed in triplicate by a flow-directed thermodilution fiberoptic continuous cardiac output catheter (OPTI-Q Sv02/CCO catheter, Abbott Critical Care Systems, North Chicago, IL). Measurements were taken every 60 seconds and recorded directly to disc. A 12-lead electrocardiogram was obtained in all patients on arrival in the ICU and 24 hours postoperatively.

Statistical analysis
All statistical analyses were performed by an independent group (Array Medical Laboratories, Indiana University, South Bend, IN). The clinical team was kept separate from data handling whenever feasible. Data and results are presented as mean ± standard error of the mean or as median and range. Continuous variables were analyzed using a Student’s t test or a Mann-Whitney rank sum test as appropriate. Categorical variables were analyzed using the {chi}2 test or Fisher’s exact test as appropriate. Repeated measures were analyzed using repeated measures analysis of variance (ANOVA). If the ANOVA was significant (p < 0.05), t tests were performed at the individual time points using the Bonferroni correction for multiple testing.

As the study populations failed the underlying assumption of normality, a Kruskal-Wallis analysis of variance on ranks test was used. The results of the ANOVA revealed significant (p < 0.001) differences among the three treatment groups. To isolate the treatment differences, Dunn’s test was used when the samples sizes were unequal, and each treatment was compared against the other in a pairwise manner with appropriate corrections. Significance of Dunn’s test is reported as p less than 0.05. All pairwise multiple comparison procedures were as follows: NCP versus PCP, p less than 0.005 NCP versus ACP, p less than 0.001 PCP versus ACP, p greater than 0.20.


    Results
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Operative data
There was no significant difference in operating time, fluid requirement, or blood loss. However, a larger volume of blood was autotransfused in the patients receiving active perfusion (ACP) (Table 2). Three patients were converted to cardiopulmonary bypass because of an intramyocardial left anterior descending coronary artery that could not be found, sudden hemodynamic compromise due to global ischemia before cardiac manipulation, and discovery of significant mitral regurgitation. These patients were eliminated from the study. Two patients were randomized to NCP and were allowed to cross over to PCP because of significant ST segment depression during grafting of the proximal left anterior descending coronary artery. These patients were left in the PCP group for the remainder of the study and analysis.


View this table:
[in this window]
[in a new window]
 
Table 2. Operative Data

 
There was no statistical difference (p < 0.05) among the treatment groups with respect to the number of grafts per patient (mean 2.9 ± 0.98), posterolateral wall revascularization (73.0%), completeness of revascularization (number of coronaries grafted/number of coronaries intended to graft, 94%), graft distribution or conduit type. The mean total ischemic time for each patient (derived from the sum of the time that each coronary artery was without distal perfusion) was significantly higher in the NCP group (23.0 ± 6.6 minutes) when compared to that in the perfusion groups, PCP (16.6 ± 5.4 minutes) and ACP (18.2 ± 7.1 minutes). There were no differences among the three groups in cardiac output or mixed venous saturation during the operation. Further analysis of certain subgroups of patients (left ventricular ejection fraction <=30%, four or more grafts, presence of cardiomegaly, and grafts to posterolateral vessels) also failed to show a difference in myocardial function.

Postoperative results
Postoperative clinical outcome data as collected by the STS National Cardiac Surgery Database was similar in all three groups. Clinical outcome data for the entire study group were as follows: operative mortality 1.3% (2/151), myocardial infarction 1.98% (3/151), stroke 0.6% (1/151), renal failure 0.6% (1/151), sternal infection 0.6% (1/151), reexploration for bleeding 2.6% (4/151), atrial fibrillation 28.4% (43/151), transfusion rate 11.2% (17/151), inotropic support 12.6% (19/151), intraaortic balloon pump use 2.6% (4/151), mean mechanical ventilation time 2.5 hours ± 5.39, mean ICU length of stay 1.0 days ± 0.28, mean hospital length of stay, 4.6 days ± 2.6, 90-day reintervention rate 3.3% (5/151 PTCA only), 90 day readmission rate 11.3% (17/151). Postoperative mediastinal drainage (mean 589 ± 478.8 mL ) was not statistically different among the three groups, but the NCP patients had a statistically significantly higher fluid requirement (p = 0.032). The cardiac indices and mixed venous saturation measurements were statistically higher in the ACP group compared to the NCP group at every 4-hour interval postoperatively (Figs 2 and 3). Comparisons were made controlling for the prevailing central venous pressures. With the exception of the first set of postoperative cardiac index measurements, the PCP group was not significantly different from the NCP group. The difference between the perfusion groups (PCP and ACP) was too small to reach statistical significance, with the exception of the SV02 measurements at time 12 hours. Creatinine phosphokinase–MB and lactic acid levels (measured at 8, 16, and 24 hours postoperatively) were not statistically significantly different among the three groups. However, Troponin I levels measured at 24 hours were lower (p = 0.023) in the ACP group (mean 0.18 ± 0.48 ng/mL) compared to the NCP group (mean 0.51 ± 0.85 ng/mL). The local laboratory reference range for normal at the 99th percentile is less than 0.04 ng/mL, and the cutoff for acute myocardial infarction is 0.5 ng/mL (Sacred Heart Hospital, Pensacola, FL).



View larger version (18K):
[in this window]
[in a new window]
 
Fig 2. Cardiac index (CI) (cardiac output/body surface area) as determined at 0, 4, 8, 12, and 16 hrs in the intensive care unit. Pairwise multiple comparisons: NCP vs PCP,p< 0.005; NCP vs ACP,p< 0.001; PCP vs ACP,p< 0.20.Postop= postoperatively.

 


View larger version (18K):
[in this window]
[in a new window]
 
Fig 3. Mixed venous saturation measured at 0, 4, 8, 12, and 16 hrs in the intensive care unit. Pairwise multiple comparisons: NCP vs PCP,p= NS; NCP vs ACP,p< 0.001; PCP vs ACP,p< 0.001.Postop= postoperatively.

 

    Comment
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 
Off-pump coronary artery bypass grafting avoids the global myocardial ischemia that occurs in arrested, on-pump bypass surgery. Similar to catheter-based intervention, off-pump techniques use intermittent ischemia, usually to a single coronary bed at a time. This study was performed for the following reasons: (1) to determine the clinical effects of the intermittent but cumulative ischemia that occurs in OPCAB grafting; and (2) to evaluate the effect of providing coronary blood flow during the operation on myocardial injury and performance. To control for biases in operative judgment and technique, a single surgeon performed all procedures. During the period of the study, all patients electively undergoing CABG were entered into the study. Cardiac positioning, stabilization techniques, and grafting order were identical in all patients. Similar, nonselected patients were randomized into one of three treatment methods (NCP, PCP, or ACP) as previously outlined. Intraoperative hemodynamic measurements failed to demonstrate a significant difference among the three treatment groups with respect to myocardial performance during the procedure itself. However, with relatively brief anastomotic times (mean 6 to 9 minutes), small degradations in myocardial function may be difficult to detect. One shortcoming of the study is that transesophageal echocardiography was not used to measure segmental wall motion scores, which has been demonstrated to affect decision making during CABG [11]. Nonetheless, we were able to detect a cumulative ischemic effect in the postoperative period. Patients in the NCP treatment arm had lower cardiac indices and mixed venous saturations in the ICU (Figs 2 and 3). Patients who underwent OPCAB with ACP performed the best of the three treatment groups, statistically significantly better than the NCP patients at every interval measured. Although the PCP patients initially performed better than the NCP patients, this difference did not persist and was not statistically significant beyond the initial ICU measurements. It is important to note that although ACP did result in improved myocardial performance, as measured by standard hemodynamic monitoring, clinical outcomes were identical across all three groups. Most patients in our study had good left ventricular function and, theoretically, greater reserve for tolerating ischemia. In addition, this study has insufficient power to demonstrate significant differences in major cardiac-related events. For the same reason, the data do not indicate whether there are subgroups (such as patients with poorly contractile or acutely ischemic ventricles) that may benefit more from this technique. We would anticipate that the ACP method might confer a more significant advantage in these subgroups of patients.

With respect to myocardial injury, the mean total ischemic time for the NCP patients (23 ± 6.6 minutes) was significantly longer (p = 0.01) than in the perfusion groups (PCP 16.6 ± 5.4 minutes, ACP 18.2 ± 7.1 minutes), as shunts were not used during the distal anastomosis and the completed free grafts were not perfused until the proximal anastomosis was completed. As a result, the Troponin I measured at 24 hours was statistically higher (p = 0.023) in the NCP group (0.51 ± 0.85 ng/mL) when compared to that in the PCP (0.26 ± 0.58 ng/mL) and ACP (0.18 ± 0.48 ng/mL) groups. In our laboratory, a Troponin I level of 0.05 ng/mL is the cutoff for acute myocardial infarction. Creatinine phosphokinase–MB levels and lactic acid release were not statistically significantly higher in the NCP group. Troponin I levels have been shown to be the most sensitive and specific in depicting myocardial ischemia and to correlate with subsequent adverse cardiac events [1214].

In conclusion, this study demonstrates that active coronary perfusion during an OPCAB procedure offers superior myocardial protection over passive or no coronary perfusion. When passive perfusion (involving a cannula with a multidelivery manifold) is used, flow is directly proportional to the prevailing arterial pressure, the quantity of grafts being perfused, and the relative vascular resistance of each of the coronary beds connected to the manifold. The net result is that under situations of hypotension and multiple grafts, the net perfusion to each graft may be less than 20 mL/min. The mechanism behind superior quantity and distribution of assisted flow relates to the simple use of an in-line pump rather than pressure-dependent passive flow. When systemic pressures fall during mechanical manipulation of the heart (as in grafting the posterior wall), coronary blood flow can be maintained at or above systemic levels. By maintaining adequate coronary flow, the negative feedback cycle of decreased systemic pressure causing decreased coronary perfusion pressure and further myocardial dysfunction is interrupted. Another potential strategy that was not used in this study is to perform the proximal anastomosis first. Although the graft flow during the operation will still be determined in part from the aortic root pressure, each graft would be connected individually to the aorta, unlike with the multidelivery manifold. However, we choose to use the multidelivery passive cannula method (PCP) most often in our everyday practice, as it prevents the need to perform the proximal anastomosis first, which we often find inconvenient. Additionally, it is a very reliable blood flow source to use for shunting as well as deairing and providing subsequent blood flow throughout the remainder of the distal anastomosis phase of the operation. However, although the PCP method is very user-friendly and inexpensive, the ACP method provides a significantly greater quantity of coronary blood flow.

We do not believe, however, that this study necessarily justifies the use of the ACP (PADCAB) technique in most OPCAB cases. Many factors can influence the amount of coronary blood flow during the operation, including (but not limited to) the use intravenous or intracoronary nitroglycerin or the maintenance of a higher perfusion pressure. To what degree intra–coronary artery nitroglycerin contributed to the improved outcome was not specifically addressed in this study, which is a potential shortcoming. The capability of infusing intracoronary nitroglycerin aids in decreasing the resistance of the vascular bed and opens collateral circulation [6, 15]. Regardless, we believe that these results provide justification for continued investigation into OPCAB myocardial protection techniques and for further development of new technology to assess the myocardium intraoperatively, such as with coronary sinus metabolites [16], online measurement of myocardial pH [17], and contrast transesophageal echocardiography. Further investigation of myocardial protection during beating heart surgery is currently underway [18].


    References
 Top
 Abstract
 Introduction
 Patients and methods
 Results
 Comment
 References
 

  1. Tasdemir O., Vural K., Karagoz H., Bayazit K. Coronary artery bypass on the beating heart without the use of extracorporeal circulation: review of 2052 cases. J Thorac Cardiovasc Surg 1998;66:68-73.
  2. Puskas J., Wright C., Ronson R., Brown W., Gott J., Guyton R. Off-pump multivessel coronary bypass via sternotomy is safe and effective. Ann Thorac Surg 1998;66:1068-1072.[Abstract/Free Full Text]
  3. Hart J., Spooner T., Pym J., et al. A review of 1582 consecutive octopus off-pump coronary bypass patients. Ann Thorac Surg 2000;70:1017-1020.[Abstract/Free Full Text]
  4. Bonatti J., Hangler H., Hormann C., Mair J., Falkensammn J., Mair P. Myocardial damage after minimally invasive coronary artery bypass grafting on the beating heart. Ann Thorac Surg 1998;66:1093-1096.[Abstract/Free Full Text]
  5. Grubitzsch H., Ansorge K., Wollert H., Eckel L. Stunned myocardium after off-pump coronary artery bypass grafting. Ann Thorac Surg 2001;71:352-355.[Abstract/Free Full Text]
  6. Guyton R., Thourani V., Puskas J., et al. Perfusion-assisted direct coronary artery bypass: selective graft perfusion in off-pump cases. Ann Thorac Surg 2000;69:171-175.[Abstract/Free Full Text]
  7. Puskas J., Thourania V., Vinton-Johansen J., Guyton R. Active perfusion of coronary grafts facilitates complex off-pump coronary artery bypass surgery. Heart Surg Forum 2001;4:65-69.[Medline]
  8. Steele M., Palmer-Steele C. Perfusion technique for perfusion-assisted direct coronary artery bypass (PADCAB). J Extra-Corpor Technol 2000;32:158-161.
  9. Sydzyik R., Stammers A., Zavadil D., Deptula J., Christensen K. Evaluation of a new generation cardioplegia administration system. J Extra-Corpor Technol 1997;29:145-153.
  10. Altman D.G., Bland J.M. How to randomize. BMJ 1999;319:703-704.[Free Full Text]
  11. Bergquist B., Bellows W., Leung J. Transesophageal echocardiography in myocardial revascularization: II. Influence on intraoperative decision-making. Anesth Analg 1996;82:1139-1145.[Abstract]
  12. Bonnefoy, Filley S., Kirkorian G., et al. Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass grafting. Chest 1998;114:482-486.[Abstract/Free Full Text]
  13. Skiba K., Szmagala P., Gburek T., Bochenek A. Cardiac troponin T release during coronary surgery using intermittent cross-clamp wit fibrillation, on-pump and offpump beating heart. Eur J Cardio-thorac Surg 1999;16:337-341.[Abstract/Free Full Text]
  14. Rao V., Ivanov J., Weisel R., Cohen G., Borger M., Mickle D. Lactate release during reperfusion predicts low cardiac output syndrome after coronary artery surgery. Ann Thorac Surg 2001;71:1924-1930.
  15. Puskas J., Vinton-Johansen J., Muraki S., Guyton R. Myocardial protection for off-pump coronary artery bypass surgery. Semin Thorac Cardiovasc Surg 2001;13:82-88.[Medline]
  16. Crittendon M. Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites. Ann Thorac Surg 2001;72:S2220-2226.[Abstract/Free Full Text]
  17. Khabbaz K., Zankoul F., Warner K. Intraoperative monitoring of the heart: II. Online management of myocardial tissue pH. Ann Thorac Surg 2001;72:S2227-2234.[Abstract/Free Full Text]
  18. Muraki S., Morris C., Budde J., et al. Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion. J Thorac Cardiovasc Surg 2001;121:570-579.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
G. N. Thomas, E. C. Martinez, F. Woitek, M. Y. Emmert, H. Sakaguchi, S. Muecke, C. N. Lee, and T. Kofidis
Off-pump coronary bypass grafting is safe and efficient in patients with left main disease and higher EuroScore
Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 616 - 620.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
K. Koizumi, H. Shin, T. Matayoshi, and R. Yozu
Comparison of active and passive coronary perfusion in off-pump coronary artery bypass grafting
Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 977 - 980.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Koshida, G. Watanabe, T. Yasuda, S. Tomita, S. Kadoya, and T. Kanamori
Portable Coronary Active Perfusion System for Off-Pump Coronary Artery Bypass Grafting
Ann. Thorac. Surg., February 1, 2006; 81(2): 706 - 710.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. E. Halkos, F. Kerendi, J. S. Corvera, N.-P. Wang, H. Kin, C. S. Payne, H.-Y. Sun, R. A. Guyton, J. Vinten-Johansen, and Z.-Q. Zhao
Myocardial protection with postconditioning is not enhanced by ischemic preconditioning
Ann. Thorac. Surg., September 1, 2004; 78(3): 961 - 969.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verma, P. W.M. Fedak, R. D. Weisel, P. E. Szmitko, M. V. Badiwala, D. Bonneau, D. Latter, L. Errett, and Y. LeClerc
Off-Pump Coronary Artery Bypass Surgery: Fundamentals for the Clinical Cardiologist
Circulation, March 16, 2004; 109(10): 1206 - 1211.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. L. Ngaage
Off-pump coronary artery bypass grafting: the myth, the logic and the science
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 557 - 570.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas A. Vassiliades, Jr
James L. Nielsen
James L. Lonquist
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vassiliades, T. A.
Right arrow Articles by Lonquist, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vassiliades, T. A., Jr
Right arrow Articles by Lonquist, J. L.
Related Collections
Right arrow Minimally invasive surgery


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS